IMPACT OF INDUCTION WITH BASILIXIMAB IN COMBINATION WITH TACROLIMUS-BASED IMMUNOSUPPRESSIVE REGIMEN IN LIVING DONOR LIVER TRANSPLANTATION.

被引:0
|
作者
Aoyagi, Takeshi [1 ]
Taniguchi, Masahiko [1 ]
Furukawa, Hiroyuki
Shimamura, Tsuyoshi [1 ]
Suzuki, Tomomi
Yamashita, Kenichiro [1 ]
Todo, Satoru [1 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Gen Surg, Sapporo, Hokkaido, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
下载
收藏
页码:S105 / S105
页数:1
相关论文
共 50 条
  • [21] Tacrolimus-Induced Encephalopathy After Pediatric Living Donor Liver Transplantation.
    Ueno, T.
    Masahata, K.
    Oowari, M.
    Nara, K.
    Uehara, S.
    Ooue, T.
    Bessho, K.
    Kondo, H.
    Usui, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 720 - 720
  • [22] Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka, K
    Lake, J
    Villamil, F
    Levy, G
    Marotta, P
    Mies, S
    de Hemptinne, B
    Otto, G
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 185 - 185
  • [23] Tacrolimus-Induced Encephalopathy After Pediatric Living Donor Liver Transplantation.
    Ueno, T.
    Masahata, K.
    Oowari, M.
    Nara, K.
    Uehara, S.
    Ooue, T.
    Bessho, K.
    Kondo, H.
    Usui, N.
    TRANSPLANTATION, 2014, 98 : 720 - 720
  • [24] A randomized trial for Tacrolimus and Steroids vs. Tacrolimus and Basiliximab in pediatric liver transplantation.
    Spada, M
    Bertani, A
    Petz, W
    Torri, E
    Sonzogni, A
    Guizzetti, M
    Lucianetti, A
    Riva, S
    Melzi, ML
    Stroppa, P
    Torre, G
    Colledan, M
    Gridelli, B
    HEPATOLOGY, 2004, 40 (04) : 473A - 473A
  • [25] Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation
    Bhorade, SM
    Jordan, A
    Villanuev, J
    Yu, A
    Kramer, H
    Vigneswaran, WT
    Garrity, ER
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (12) : 1570 - 1575
  • [26] A randomized trial for tacrolimus and steroids vs. tacrolimus and basiliximab in pediatric liver transplantation.
    Spada, M
    Bertani, A
    Colledan, M
    Sonzogni, A
    Guizzetti, M
    Lucianetti, A
    Riva, S
    Torre, G
    Gridelli, B
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 57 - 57
  • [27] Donor outcomes of living donor liver transplantation.
    Renz, JF
    Roberts, JP
    Ascher, NL
    Lim, RC
    Emond, JC
    Rosenthal, P
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 110A - 110A
  • [28] Donor Evaluation in Living Donor Liver Transplantation.
    Dirican, Abuzer
    Baskiran, Adil
    Dogan, Murat
    Ates, Mustafa
    Ozdemir, Fatih
    Isik, Burak
    Yilmaz, Sezai
    LIVER TRANSPLANTATION, 2013, 19 : S190 - S190
  • [29] Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation.
    Boillot, O
    Baulieux, J
    Wolf, P
    Messner, M
    Cherqui, D
    Gugenheim, J
    Pageaux, G
    Belghiti, J
    Calmus, Y
    Treut, YL
    Neau-Cransac, M
    Samuel, D
    HEPATOLOGY, 1999, 30 (04) : 310A - 310A
  • [30] HIGH INCIDENCE OF HISTOLOGICAL HEPATITIS AND PORTAL FIBROSIS AT 1 YEAR AFTER PEDIATRIC LIVER TRANSPLANTATION USING A TACROLIMUS-BASED IMMUNOSUPPRESSIVE REGIMEN
    Scheenstra, Rene
    Gouw, Annette S.
    Peeters, Paul M.
    Verkade, Henkjan J.
    HEPATOLOGY, 2008, 48 (04) : 1033A - 1034A